Hepatitis

Infectious Diseases of the Fetus and Newborn Infant

Volumn , Issue , 2006, Pages 823-843

  Bradley, John S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956683995     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160537-0/50027-X     Document Type: Chapter

References (198)

1. The 2003 Report of the Committee on Infectious Diseases 2003, American Academy of Pediatrics, Ill, American Academy of Pediatrics, Elk Grove.
2. Baroudy BM, Ticehurst JR, Miele TA, et al. Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase. Proc Natl Acad Sci U S A 1985, 82:2143-2147.
3. Costa-Mattioli M, Di Napoli A, Ferre V, et al. Genetic variability of hepatitis A virus. J Gen Virol 2003, 84:3191-3201.
4. Cuthbert JA Hepatitis A: old and new. Clin Microbiol Rev 2001, 14:38-58.
5. Cromeans T, Fields HA, Sobsey MD Replication kinetics and cytopathic effect of hepatitis A virus. J Gen Virol 1989, 70:2051-2062.
6. Debray D, Cullufi P, Devictor D, et al. Liver failure in children with hepatitis A. Hepatology 1997, 26:1018-1022.
7. Fagan EA, Hadzic N, Saxena R, Mieli-Vergani G Symptomatic neonatal hepatitis A disease from a virus variant acquired in utero. Pediatr Infect Dis J 1999, 18:389-391.
8. Feinstone SM, Kapikian AZ, Purceli RH Hepatitis A detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science 1973, 182:1026-1028.
9. Gingrich GA, Hadler SC, Elder HA, Ash KO Serologic investigation of an outbreak of hepatitis A in a rural day-care center. Am J Public Health 1983, 73:1190-1193.
10. Hadler SC, Webster HM, Erben JJ, et al. Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med 1980, 302:1222-1227.
11. Krugman S Viral hepatitis A identified by CF and immune adherence. N Engl J Med 1975, 292:1141-1143.
12. Krugman S Viral hepatitis: A, B, C, D and E infection. Pediatr Rev 1992, 13:203-212.
13. Klein BS, Michaels JA, Rytel MW, et al. Nosocomial hepatitis A: a multinursery outbreak in Wisconsin. JAMA 1984, 252:2716-2721.
14. Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985, 122:226-233.
15. Leikin E, Lysikiewicz A, Garry D, Tejani N Intrauterine transmission of hepatitis A virus. Obstet Gynecol 1996, 88:690-691.
16. Lemon SM The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood products. Vox Sang 1994, 67(Suppl 4):19-23.
17. McCaustland KA, Bond WW, Bradley DW, et al. Survival of hepatitis A virus in feces after drying and storage for 1 month. J Clin Microbiol 1982, 16:957-958.
18. Muecke CJ, Beliveau C, Rahme E, et al. Hepatitis A seroprevalence and risk factors among day-care educators. Clin Invest Med 2004, 27:259-264.
19. Najarian R, Caput D, Gee W, et al. Primary structure and gene organization of human hepatitis A virus. Proc Natl Acad Sci U S A 1985, 82:2627-2631.
20. Normann A, Jung C, Vallbracht A, Flehmig B Time course of hepatitis A viremia and viral load in the blood of human hepatitis A patients. J Med Virol 2004, 72:10-16.
21. Rakela J, Mosley JW Fecal excretion of hepatitis A virus in humans. J Infect Dis 1977, 135:933-938.
22. Rosenblum LS, Villarino ME, Nainan OV, et al. Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991, 164:476-482.
23. Schiodt FV, Davern TJ, Shakil AO, et al. Viral hepatitis-related acute liver failure. Am J Gastroenterol 2003, 98:448-453.
24. Shapiro CN, Hadler SC Hepatitis A and hepatitis B virus infections in day-care settings. Pediatr Ann 1991, 20:435-441.
25. Shaw FE, Sudman JH, Smith SM, et al. A community-wide epidemic of hepatitis A in Ohio. Am J Epidemiol 1986, 123:1057-1065.
26. Silberstein E, Dveksler G, Kaplan GG Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1. J Virol 2001, 75:717-725.
27. Sjogren M Immunization and the decline of viral hepatitis as a cause of acute liver failure. Hepatology 2003, 38:554-556.
28. Stapleton JT Host immune response to hepatitis A virus. J Infect Dis 1995, 171(Suppl 1):S9-S14.
29. Storch GA, Bodicky C, Parker M, et al. Use of conventional and IgM-specific radioimmunoassays for anti-hepatitis A antibody in an outbreak of hepatitis A. Am J Med 1982, 73:663-668.
30. Tanaka I, Shima M, Kubota Y, et al. Vertical transmission of hepatitis A. Lancet 1995, 345:397.
31. Tassopoulos NC, Papaevangelou GJ, Ticehurst JR, Purcell RH Fecal excretion of Greek strains of hepatitis A virus in patients with hepatitis A and in experimentally infected chimpanzees. J Infect Dis 1986, 154:231-237.
32. Ticehurst JR Hepatitis A virus: clones, cultures, and vaccines. Semin Liver Dis 1986, 6:46-55.
33. Tong MJ, Thursby M, Rakela J, et al. Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology 1981, 80:999-1004.
34. Vallbracht A, Maier K, Stierhof YD, et al. Liver-derived cytotoxic T cells in hepatitis A virus infection. J Infect Dis 1989, 160:209-217.
35. Watson JC, Fleming DW, Borella AJ, et al. Vertical transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit. J Infect Dis 1993, 167:567-571.
36. Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983, 3:135-141.
37. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983, 2:1099-1102.
38. Beasley RP Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988, 61:1942-1956.
39. Bortolotti F Treatment of chronic hepatitis B in children. J Hepatol 2003, 39(Suppl 1):S200-S205.
40. Bouchard MJ, Schneider RJ The enigmatic X gene of hepatitis B virus. J Virol 2004, 78:12725-12734.
41. Boxall EH, Flewett TH, Dane DS, et al. Hepatitis B surface antigen in breast milk. Lancet 1974, 2:1007-1008.
42. Boxall EH, Sira J, Standish RA, et al. Natural history of hepatitis B in perinatally infected carriers. Arch Dis Child Fetal Neonatal Ed 2004, 89:F456-F460.
43. Broderick A, Jonas MM Management of hepatitis B in children. Clin Liver Dis 2004, 8:387-401.
44. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991, 40(RR-130):1-19. Centers for Disease Control and Prevention.
45. Chang MH, Lee CY, Chen DS, et al. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 1987, 111:34-39.
46. Chang MH Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Int 2003, 23:309-314.
47. Chen WN, Oon CJ Human hepatitis B virus mutants: significance of molecular changes. FEBS Lett 1999, 453:237-242.
48. Dane DS, Cameron CH, Briggs M Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1970, 1:695.
49. Dinsmoor MJ Hepatitis in the obstetric patient. Infect Dis Clin North Am 1997, 11:77-91.
50. Fiore AE Chronic maternal hepatitis B infection and premature rupture of membranes. Pediatr Infect Dis J 2002, 21:357-358.
51. Ganem D Assembly of hepadnaviral virions and subviral particles. Curr Top Microbiol Immunol 1991, 168:61-83.
52. Ganem D, Prince AM Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
53. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 2003, 348:800-807.
54. Heerman KH, Goldmann U, Schwartz W, et al. Large surface proteins of hepatitis B virus containing the pre-S sequence. J Virol 1984, 52:396-402.
55. Hill JB, Sheffield JS, Kim MJ, et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002, 99:1049-1052.
56. Hom X, Little NR, Gardner SD, Jonas MM Predictors of virologic response to lamivudine treatment in children with chronic hepatitis B infection. Pediatr Infect Dis J 2004, 23:441-445.
57. Hwang LY, Beasley RP, Stevens CE, Szmuness W Immunogenicity of HBV vaccine in healthy Chinese children. Vaccine 1983, 1:10-12.
58. Jonas MM, Mizerski J, Badia IB, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002, 346:1706-1713.
59. Kattamis CA, Demetrios D, Matsaurotis NS Australia antigen and neonatal hepatitis syndrome. Pediatrics 1974, 54:157-164.
60. Komatsu H, Inui A, Morinishi Y, et al. Sequence analysis of hepatitis B virus genomes from an infant with acute severe hepatitis and a hepatitis B e antigen-positive carrier mother. J Med Virol 2001, 65:457-462.
61. Lai CL, Ratziu V, Yuen MF, Poynard T Viral hepatitis B. Lancet 2003, 362:2089-2094.
62. Larouze B, et al. Host response to hepatitis-B infection in patients with primary hepatic carcinoma and families: a case/control study in Senegal, West Africa. Lancet 1976, 2:534-538.
63. Lee AKY, Ip HMH, Wong VCW Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis 1978, 138:668-671.
64. Lee JY, Locarnini S Hepatitis B virus: pathogenesis, viral intermediates, and viral replication. Clin Liver Dis 2004, 8:301-320.
65. Lemon SM What is the role of testing for IgM antibody to core antigen of hepatitis B virus?. Mayo Clin Proc 1988, 63:201-204.
66. Lindsay KL, Nizze JA, Koretz R, et al. Diagnostic usefulness of testing for anti-HBc IgM in acute hepatitis B. Hepatology 1986, 6:1325-1328.
67. Linnemann CC, Goldberg S HBAg in breast milk. Lancet 1974, 2:155.
68. Lo KJ, Lee SD, Tsai YT, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers. Hepatology 1988, 8:1647-1650.
69. Lolekha S, Warachit B, Hirunyachote A, et al. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine 2002, 20:3739-3743.
70. Marcellin P, Chang TT, Lim SG, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003, 348:808-816.
71. Marcellin P, Lau GK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2004, 351:1206-1217.
72. sAg carrier state in children. Lancet 1981, 1:289-292.
73. Mele A, Stroffolini T, Zanetti AR Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. J Med Virol 2002, 67:440-443.
74. Milne A, West DJ, Chinh DV, et al. Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants. J Med Virol 2002, 67:327-333.
75. Moroy T, Marchio A, Etiemble J, et al. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 1986, 324:276-279.
76. Okada K, Yarnada T, Mijakawa Y, et al. Hepatitis B surface antigen in the serum of infants after delivery from asymptomatic carrier mothers. J Pediatr 1975, 87:360-363.
77. Okada K, Kamiyama I, Inomata M, et al. e antigen and anti- e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976, 294:746-749.
78. Oon CJ, Lim GK, Ye Z, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995, 13:699-702.
79. Pawlotsky JM Molecular diagnosis of viral hepatitis. Gastroenterology 2002, 122:1554-1568.
80. Pawlotsky JM Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J Hepatol 2003, 39(Suppl 1):S31-S35.
81. Penna A, Artini M, Cavalli A, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996, 98:1185-1194.
82. Poovorawan Y, Sanpavat S, Pongpunglert W, et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatr Infect Dis J 1992, 11:816-821.
83. Raimondo G, Schneider R, Stemler M, et al. A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis. Virology 1990, 179:64-68.
84. Ranger-Rogez S, Denis F Hepatitis B mother-to-child transmission. Expert Rev Anti Infect Ther 2004, 2:133-145.
85. Rehermann B, Chang KM, McHutchinson J, et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996, 70:7092-7102.
86. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996, 2:1104-1108.
87. Rehermann B, Chisari FV Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol 2000, 242:299-325.
88. Rehermann B Immune responses in hepatitis B virus infection. Semin Liver Dis 2003, 23:21-38.
89. Saltik-Temizel IN, Kocak N, Demir H Interferon-alpha and lamivudine combination therapy of children with chronic hepatitis b infection who were interferon-alpha nonresponders. Pediatr Infect Dis J 2004, 23:466-468.
90. Saltik-Temizel IN, Kocak N, Demir H Lamivudine and high-dose interferon-alpha combination therapy for naïve children with chronic hepatitis B infection. J Clin Gastroenterol 2005, 39:68-70.
91. Schmitt S, Glebe D, Tolle TK, et al. Structure of pre-S2 N- and O- linked glycans in surface proteins from different genotypes of hepatitis B virus. J Gen Virol 2004, 85:2045-2053.
92. Schweitzer IL, Wing A, McPeak C, et al. Hepatitis and hepatitis-associated antigen in 56 mother-infant pairs. JAMA 1972, 220:1092-1095.
93. Schweitzer IL, Dunn AE, Peters RL, et al. Viral hepatitis B in neonates and infants. Am J Med 1973, 55:762-771.
94. Schweitzer IL, Moseley JW, Ashcavai M, et al. Factors influencing neonatal infection by hepatitis B virus. Gastroenterology 1973, 65:227-283.
95. Schweitzer IL Vertical transmission of the hepatitis B surface antigen. Am J Med Sci 1975, 270:287-291.
96. Servoss JC, Friedman LS Serologic and molecular diagnosis of hepatitis B virus. Clin Liver Dis 2004, 8:267-281.
97. Shields MT, Taswell HF, Czaja AJ, et al. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterology 1987, 93:675-680.
98. Skinhoj P, Sardemann H, Cohen J Hepatitis associated antigen (HAA) in pregnant women and their newborn infants. Am J Dis Child 1972, 123:380-381.
99. Soderstrom A, Norkrans G, Lindh M Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003, 35:814-819.
100. Stevens CE, Beasley RP, Tsui J, et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975, 292:771-774.
101. Stevens CE, Neurath RA, Beasley P, et al. HBeAg and anti HBe detection by radioimmunoassay correlation with vertical transmission of HBV in Taiwan. J Med Virol 1979, 3:237-241.
102. Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987, 257:2612-2616.
103. Stibbe W, Gerlich WH Variable protein composition of hepatitis B surface antigen from different donors. Virology 1982, 123:436-442.
104. Stiehm ER, Keller MA Breast milk transmission of viral disease. Adv Nutr Res 2001, 10:105-122.
105. Szmuness W Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 1978, 24:40-69.
106. Tedder RS, Ijaz S, Gilbert N, et al. Evidence for a dynamic host - parasite relationship in e-negative hepatitis B carriers. J Med Virol 2002, 68:505-512.
107. Tiollais P, Dejean A, Brechot C, et al. Structure of hepatitis B virus DNA. Viral Hepatitis and Liver Disease 1984, 49-65. Grune & Stratton, New York. G.N. Vyas, J.L. Dienstag, J.H. Hoofnagle (Eds.).
108. Tran TT, Martin P Hepatitis B: epidemiology and natural history. Clin Liver Dis 2004, 8:255-266.
109. van Zonneveld M, van Nunen AB, Niesters HG, et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003, 10:294-297.
110. Vitvitski L, Trepo C, Prince AM, et al. Detection of virus-associated antigen in serum and liver of patients with non-A, non-B hepatitis. Lancet 1979, 32:1263-1267.
111. Wands JR, Fujita YK, Isselbacher KJ, et al. Identification and transmission of hepatitis B virus-related variants. Proc Natl Acad Sci U S A 1986, 83:6608-6612.
112. Wai CT, Fontana RJ Clinical significance of hepatitis B virus genotypes, variants, and mutants. Clin Liver Dis 2004, 8:321-352.
113. Wieland S, Thimme R, Purcell RH, Chisari FV Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 2004, 101:6669-6674.
114. Wu JS, Hwang LY, Goodman KJ, Beasley RP Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999, 179:1319-1325.
115. Yang YJ, Liu CC, Chen TJ, et al. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Pediatr Infect Dis J 2003, 22:584-588.
116. Young BW, Lee SS, Lim WL, Yeoh EK The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers. J Viral Hepat 2003, 10:23-30.
117. Zhang SL, Yue YF, Bai GQ, et al. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004, 10:437-438.
118. Viral hepatitis in pregnancy. No. 248, July 1998. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1998, 63:195-202. ACOG educational bulletin.
119. Bradley DW, Maynard JE Etiology and natural history of post-transfusion and enterically-transmitted non A, non-B hepatitis. Semin Liver Dis 1986, 6:56-66.
120. Caudai C, Battiata M, Riccardi MP, et al. Vertical transmission of the hepatitis C virus to infants of anti-human immunodeficiency virus-negative mothers: molecular evolution of hypervariable region 1 in prenatal and perinatal or postnatal infections. J Clin Microbiol 2003, 41:3955-3959.
121. Cerny A, Chisari FV Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999, 30:595-601.
122. Choo QL, Weiner AJ, Overby LR, et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990, 46:423-441.
123. Conte D, Colucci A, Minola E, et al. Clinical course of pregnant women with chronic hepatitis C virus infection and risk of mother-to-child hepatitis C virus transmission. Dig Liver Dis 2001, 33:366-371.
124. Darling JM, Wright TL Immune responses in hepatitis C: is virus or host the problem?. Curr Opin Infect Dis 2004, 17:193-198.
125. FDA. http://www.fda.gov/cder/foi/label/2004/103132_5064lbl.pdf.
126. Ferrero S, Lungaro P, Bruzzone BM, et al. Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-year survey (1990-2000). Acta Obstet Gynecol Scand 2003, 82:229-234.
127. Germer JJ, Zein NN Advances in the molecular diagnosis of hepatitis C and their clinical implications. Mayo Clin Proc 2001, 76:911-920.
128. Giacchino R, Tasso L, Timitilli A, et al. Vertical transmission of hepatitis C virus infection: usefulness of viremia detection in HIV-seronegative hepatitis C virus-seropositive mothers. J Pediatr 1998, 132:167-169.
129. Giles M, Hellard M, Sasadeusz J Hepatitis C and pregnancy: an update. Aust N Z J Obstet Gynaecol 2003, 43:290-293.
130. Granovsky MO, Minkoff HL, Tess BH, et al. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 1998, 102:355-359.
131. Hadzic N Hepatitis C in pregnancy. Arch Dis Child Fetal Neonatal Ed 2001, 84:F201-F204.
132. Hoofnagle JH Course and outcome of hepatitis C. Hepatology 2002, 36(5 Suppl 1):S21-S29.
133. Hupertz VF, Wyllie R Perinatal hepatitis C infection. Pediatr Infect Dis J 2003, 22:369-372.
134. Jara P, Resti M, Hierro L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003, 36:275-280.
135. Jonas MM Children with hepatitis C. Hepatology 2002, 36(5 Suppl 1):S173-S178.
136. Lauer GM, Walker BD Hepatitis C virus infection. N Engl J Med 2001, 345:41-52.
137. Lauer GM, Barnes E, Lucas M, et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 2004, 127:924-936.
138. Li DY, Schwarz KB Immunopathogenesis of chronic hepatitis C virus infection. J Pediatr Gastroenterol Nutr 2002, 35:260-267.
139. Mast EE Mother-to-infant hepatitis C virus transmission and breastfeeding. Adv Exp Med Biol 2004, 554:211-216.
140. Neumann-Haefelin C, Blum HE, Chisari FV, Thimme R T cell response in hepatitis C virus infection. J Clin Virol 2005, 32:75-85.
141. Orland JR, Wright TL, Cooper S Acute hepatitis C. Hepatology 2001, 33:321-327.
142. Pappalardo BL Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis. Int J Epidemiol 2003, 32:727-734.
143. Pawlotsky JM Use and interpretation of hepatitis C virus diagnostic assays. Clin Liver Dis 2003, 7:127-137.
144. Pearlman BL Hepatitis C treatment update. Am J Med 2004, 117:344-352.
145. Pembrey L, Newell ML, Peckham C Is there a case for hepatitis C infection screening in the antenatal period?. J Med Screen 2003, 10:161-168.
146. Penin F, Dubuisson J, Rey FA, et al. Structural biology of hepatitis C virus. Hepatology 2004, 39:5-19.
147. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998, 282:938-941.
148. Plunkett BA, Grobman WA Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: a cost-effectiveness analysis. Am J Obstet Gynecol 2004, 191:998-1003.
149. Racanelli V, Rehermann B Hepatitis C virus infection: when silence is deception. Trends Immunol 2003, 24:456-464.
150. Resti M, Azzari C, Mannelli F, et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998, 317:437-441.
151. Resti M, Jara P, Hierro L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 2003, 70:373-377.
152. Roberts EA, Yeung L Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002, 36(5 Suppl 1):S106-S113.
153. Ruiz-Extremera A, Salmeron J, Torres C, et al. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breast-feeding in transmission. Pediatr Infect Dis J 2000, 19:511-516.
154. Schuval S, Van Dyke RB, Lindsey JC, et al. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol. Arch Pediatr Adolesc Med 2004, 158:1007-1013.
155. + T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003, 197:1645-1655.
156. Simmonds P Genetic diversity and evolution of hepatitis C virus- 15 years on. J Gen Virol 2004, 85:3173-3188.
157. Steininger C, Kundi M, Jatzko G, et al. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 2003, 187:345-351.
158. Thimme R, Oldach D, Chang KM, et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001, 194:1395-1406.
159. Thimme R, Bukh J, Spangenberg HC, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 2002, 99:15661-15668.
160. Thomas SL, Newell ML, Peckham CS, et al. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 1998, 27:108-117.
161. Casey JL Hepatitis delta virus: molecular biology, pathogenesis and immunology. Antivir Ther 1998, 3(Suppl 3):37-42.
162. Denniston KJ, Hoyer BH, Smedile A, et al. Cloned fragment of the hepatitis delta virus RNA genome: sequence and diagnostic application. Science 1986, 232:873-875.
163. Farci P Delta hepatitis: an update. J Hepatol 2003, 39(Suppl 1):S212-S219.
164. + T-cell epitopes on hepatitis delta virus. J Gen Virol 2004, 85:3089-3098.
165. Kos A, Dijkema R, Arnberg AC, et al. The hepatitis delta virus possesses a circular RNA. Nature 1986, 323:558-560.
166. Niro GA, Casey JL, Gravinese E, et al. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol 1999, 30:564-569.
167. Niro GA, Rosina F, Rizzetto M Treatment of hepatitis D. J Viral Hepat 2005, 12:2-9.
168. + T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol 1997, 71:2241-2251.
169. Polish LB, Gallagher M, Fields HA, Hadler SC Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 1993, 6:211-229.
170. Rizzetto M, Canese MG, Gerin JL, et al. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980, 141:590-602.
171. Wang KS, Choo QL, Weiner AJ, et al. Structure, sequence and expression of the hepatitis delta viral genome. Nature 1986, 323:508-514.
172. Arankalle VA, Chadha MS, Mehendale SM, Tungatkar SP Epidemic hepatitis E: serological evidence for lack of intrafamilial spread. Indian J Gastroenterol 2000, 19:24-28.
173. Balayan MS, Adnjaparidz AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983, 20:23-31.
174. Balayan MS HEV infection: historical perspectives, global epidemiology, and clinical features. Viral Hepatitis and Liver Disease 1991, 498-501. Williams & Wilkins, Baltimore. F.B. Hollinger, S.M. Lemon, H.S. Margolis (Eds.).
175. Bradley DW Hepatitis E virus: a brief review of the biology, molecular virology, and immunology of a novel virus. J Hepatol 1995, 22(1 Suppl):140-145.
176. Chibber RM, Usmani MA, Al-Sibai MH Should HEV infected mothers breast feed?. Arch Gynecol Obstet 2004, 270:15-20.
177. Emerson SU, Purcell RH Hepatitis E virus. Rev Med Virol 2003, 13:145-154.
178. Emerson SU, Purcell RH Running like water-the omnipresence of hepatitis E. N Engl J Med 2004, 351:2367-2368.
179. Favorov MO, Fields HA, Purdy MA, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992, 36:246-250.
180. Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg 2000, 62:519-523.
181. Jaiswal SP, Jain AK, Naik G, et al. Viral hepatitis during pregnancy. Int J Gynaecol Obstet 2001, 72:103-108.
182. Khuroo MS, Kamili S, Jameel S Vertical transmission of hepatitis E virus. Lancet 1995, 22:1025-1026.
183. Krawczynski K, Aggarwal R, Kamili S Hepatitis E. Infect Dis Clin North Am 2000, 14:669-687.
184. Kumar A, Beniwal B, Kar P, et al. Hepatitis E in pregnancy. Obstet Gynecol Surv 2005, 60:7-8.
185. Singh S, Mohanty A, Joshi YK, et al. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003, 70:37-39.
186. Ticehurst J Identification and characterization of hepatitis E virus. Viral Hepatitis and Liver Disease 1991, 501-513. Williams & Wilkins, Baltimore. F.B. Hollinger, S.M. Lemon, H.S. Margolis (Eds.).
187. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 1994, 91:10198-10202.
188. Worm HC, van der Poel WH, Brandstatter G Hepatitis E: an overview. Microbes Infect 2002, 4:657-666.
189. Yarbough PO Hepatitis E virus. Advances in HEV biology and HEV vaccine approaches. Intervirology 1999, 42:179-184.
190. Barqasho B, Naver L, Bohlin AB, et al. GB virus C coinfection and vertical transmission in HIV-infected mothers before the introduction of antiretroviral prophylaxis. HIV Med 2004, 5:427-430.
191. Fischler B, Lara C, Chen M, et al. Genetic evidence for mother-to-infant transmission of hepatitis G virus. J Infect Dis 1997, 176:281-285.
192. Linnen J, Wages J, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996, 271:505-508.
193. Pessoa MG, Terrault NA, Detmer J, et al. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 1998, 27:877-880.
194. Ross RS, Viazov S, Schmitt U, et al. Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world. J Med Virol 1998, 54:103-106.
195. Schroter M, Polywka S, Zollner B, et al. Detection of TT virus DNA and GB virus type C/hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission. J Clin Microbiol 2000, 38:745-747.
196. Stapleton JT GB virus type C/hepatitis G virus. Semin Liver Dis 2003, 23:137-148.
197. Stapleton JT, Williams CF, Xiang J GB virus type C: a beneficial infection?. J Clin Microbiol 2004, 42:3915-3919.
198. Wejstal R, Manson AS, Widell A, Norkrans G Perinatal transmission of hepatitis G virus (GB virus type C) and hepatitis C virus infections-a comparison. Clin Infect Dis 1999, 28:816-821.